Clinical trial

Real World Analysis on Lymphocyte Reconstitution After Lymphopenia in Participants Treated by Tecfidera

NCT04756687

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2021-03-10

PhaseN/A

Study timeline

Study start (actual)2021-03-10Date precision: day

Registry last updated2023-10-23

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Multiple Sclerosisunresolved

Multiple Sclerosis, Relapsing-Remittingunresolved

Interventions

Dimethyl fumarateDRUG · verified · RxNorm: dimethyl fumarate

Sponsors & collaborators

Biogenlead sponsor

Mapped research locations

ToulouseFrance1 MarseilleFrance1 MontpellierFrance1 LyonFrance1 StrasbourgFrance1 LilleFrance1 BordeauxFrance1 NantesFrance1 RennesFrance1 NiceFrance1 DijonFrance1 CaenFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04756687 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.